ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0932

The Landscape of Immune Cells in Systematic Lupus Erythematosus Patients with Epstein-Barr Virus Infection by Single-cell Sequencing

Lingzhen Hu1, Jianxin Tu1, Jiajun Gui2, Mengyuan Fang2, Xiaowei Chen1 and Li Sun1, 1The First Affliated Hospital of Wenzhou Medical University, Wenzhou, China, 2The First Clinical College, Wenzhou Medical University, Wenzhou, China

Meeting: ACR Convergence 2023

Keywords: B-Lymphocyte, Infection, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (0899–0933) SLE – Etiology & Pathogenesis Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: This study aimed to analyze the immune cell profiles, especially B cells and B-cell receptor (BCR) of systematic lupus erythematosus (SLE) patients with or without Epstein-Barr virus (EBV) infection, and to identify the differences between the two groups.

Methods: We included 2 cases of SLE patients with EBV infection (P-SLE), 4 cases of SLE patients without EBV infection (N-SLE), and 2 cases of healthy controls (HC). Using single-cell RNA sequencing (scRNA-seq) to interrogate the heterogeneity of cell populations by combining the transcriptomic profile and BCR repertoire.

Results: 83478 cells were obtained in our study and were divided into 8 major cell types or subtypes, including B cells, CD4+ T cells, CD8+ T cells, other T cells, natural killer (NK) cells, monocytes, dendritic cells (DCs) and other cells. There is no significant difference in the proportion of cell clusters between P-SLE and N-SLE. Interferon-alpha/beta pathways were upregulated in T cells, monocytes, and B cells in P-SLE compared with N-SLE. B cells were further divided into four different clusters, including naive B cells, intermediate B cells, memory B cells, and plasmablast. For V gene segments in the heavy chain, IGHV3, IGHV4, and IGHV2 gene families were frequently used in both patients and HC, especially IGHV3 and IGHV4 families. However, the frequencies of gene segments in each IGHV family were significantly different between the three groups. We also found that the BCR diversity was significantly reduced in P-SLE compared with N-SLE and HC. Moreover, IgM presents the largest proportion in all BCR repertoire, but its proportion was significantly decreased in P-SLE patients. We also observed that the proportions of IgG1, IgG3, and IgA1 were significantly increased in P-SLE than that in HC or N-SLE.

Conclusion: Our study provides a comprehensive characterization of the immune cell profiles and BCR repertoire in SLE patients with or without EBV infection, which contributes to the understanding of the mechanism for the immune response to EBV infection in SLE patients.

Supporting image 1

Figure 1. Study design and single-cell transcriptional profiling of PBMCs from HCs and SLE patients with or without EBV. A. The schematic shows the study design. B. Cellular populations identified from 2 P-SLE, 4 N-SLE, and 2 HC, showing the formation of 8 clusters with the respective labels. Each dot corresponds to a single cell, colored according to cell type. C. A UMAP plot representing the 8 clusters across 83478 PBMCs from 8 individuals (2 P-SLE, 4 N-SLE, and 2 HC). The cluster labels were added manually. D. Violin plots comparing the proportion of each cluster between P-SLE(n=2) and N-SLE(n=4). The results for P-SLE are shown in purple, and those for N-SLE are in green, each dot corresponds to a sample. The P values were calculated using a Wilcoxon test.

Supporting image 2

Figure 2. Comparison of B cells single-cell landscapes and BCR between P-SLE, N-SLE, and HC. A. UMAP plots representing four B cell clusters with the respective labels. B. Comparison of variable (V) and joining (J) gene usage in BCR heavy chain between three groups. C. The clonal diversity of P-SLE, N-SLE, and HC. D. Analysis of Ig isotypes in three groups.


Disclosures: L. Hu: None; J. Tu: None; J. Gui: None; M. Fang: None; X. Chen: None; L. Sun: None.

To cite this abstract in AMA style:

Hu L, Tu J, Gui J, Fang M, Chen X, Sun L. The Landscape of Immune Cells in Systematic Lupus Erythematosus Patients with Epstein-Barr Virus Infection by Single-cell Sequencing [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/the-landscape-of-immune-cells-in-systematic-lupus-erythematosus-patients-with-epstein-barr-virus-infection-by-single-cell-sequencing/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-landscape-of-immune-cells-in-systematic-lupus-erythematosus-patients-with-epstein-barr-virus-infection-by-single-cell-sequencing/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology